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METHOD FOR ANALYZING MOLECULAR 
EXPRESSION OR FUNCTION IN AN INTACT 
SINGLE CELL 
CONTINUING DATA 
The present application claims the bene?t of priority to 
US. Provisional application No. 60/148,563, ?led Aug. 13, 
1999; and No. 60/157,849, ?led Oct. 6, 1999. The contents 
of these provisional applications are incorporated herein by 
reference in their entirety. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present application is directed to a single cell prepa 
ration method, or a brain cell preparation that provides 
near-optimal conditions for the accurate quantitation of gene 
expression in the single cell or neuron. The present invention 
also provides for a method for studying the functional 
activity in the same single cell. Also, the method of the 
present invention relates to the collection of a single neuron, 
With its membrane and dendritic processes substantially 
intact and With a full set of mRNA transcripts. 
2. Brief Description of the Related Art 
With the remarkable explosion in gene expression “chip” 
technology in recent years it appears that it Will soon be 
possible, perhaps routine, to measure the expression of 
hundreds or thousands of genes simultaneously, under a 
Wide variety of physiological and pathological conditions. In 
the foreseeable future, this neW technology Will clearly 
overWhelm our capacity to analyZe the functional implica 
tions of even a fraction of the gene expression patterns that 
Will be found. Taking the central nervous system (CNS) as 
an example, eventually unraveling the complex linkages 
betWeen multiple gene expression and CNS function Will 
likely require studies of physiological properties in the same 
neuron in Which multiple gene expression is also assessed. 
In turn, such studies Will depend on the availability of 
highly specialiZed preparations. An optimal CNS prepara 
tion for relating gene expression to function in the same 
neuron should seemingly have three major attributes: 1) the 
ability to perform extensive functional studies on the same 
single neuron that is subsequently collected for gene expres 
sion analysis; 2) the ability to collect the full set of mRNA 
transcripts from that same neuron; and 3) the ability to 
collect the neuron With most of its processes intact, in order 
to preserve subcellular and dendritic mRNA distribution. 
HoWever, the main preparations commonly used in brain 
studies of gene expression, including assays in homogeniZed 
tissues (RNAse protection assays, Northerns), in situ 
hybridiZation, acutely dissociated neurons, or electrophysi 
ological recording With extraction of cytoplasmic contents 
(e.g., in non-dissociated slices or cultures), do not provide 
optimal conditions for parallel measures of function and 
gene expression in the same neuron. In particular, none of 
these approaches routinely alloWs for the collection of the 
entire cell, including such specialiZed cells as neurons With 
their dendritic processes intact. Without a full set of mRNA 
transcripts, accurate estimates of speci?c mRNA content are 
dif?cult to obtain, and speci?c dendritically-targeted 
mRNAs are lost. 
Gray et al. discloses a partially-dissociated hippocampal 
slice (e.g., the “Zipper slice” Which gradually opens—or 
unZips—along the cell body layers) in young guinea pigs to 
provide improved accessibility to neurons for patch clamp 
pipettes. HoWever, Gray et al. does not disclose the method 
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of the invention Whereby a substantially intact single cell is 
isolated Whereby substantially all of the mRNA is detected. 
The invention brings together technology encompassing 
cutting edge instrumentation for electrophysiology, confocal 
laser scanning microscopy (CLSM), immunoautoradiogra 
phy and histochemistry, real-time detection of PCR kinetics 
and neW DNA “chip” technology (GeneChip Scanner and 
Analysis Suite), to optimiZe and extend the invention. 
While there is clearly groWing recognition of the value of 
single cell expression-function studies in the CNS, it seems 
less Well recogniZed that the preparations that are most 
Widely available for linking function to gene expression in 
single cells are signi?cantly limited in their usefulness for 
these purposes. For example, the physiological recording 
methods in Which cytoplasm is extracted through a pipette, 
do not yield the full complement of the cell’s mRNA nor do 
they alloW correlations With topographic mRNA distribu 
tion. The proportion of total mRNA extracted varies so 
greatly from one cell to another that there have been feW 
attempts to estimate the total amount of any mRNA species 
in a given neuron, or even to estimate relative or semi 
quantitative levels. The observations based on this method to 
date have been generally limited to all-or-none types of 
?ndings, regarding, for example, Whether or not a gene is 
expressed in a given cell, or in some cases, Whether its ratio 
of expression to other genes (e.g., for different receptor 
subunits) is changed (e. g., SudWeeks and TWyman, 1995). In 
contrast, semi-quantitative or quantitative estimates of the 
absolute amount of expression of a gene in a cell generally 
requires collecting the entire complement of a neuron’s 
mRNA transcripts. This seems particularly critical for stud 
ies on function-expression correlation in the same cells since 
the physiological/pathological properties of a cell (e.g., 
density of channels or receptors, developmental stage, bio 
chemical phenotype or pathological change) may Well 
re?ect total level of a gene’s expression rather than the ratio 
to another gene’s expression, Which might also be altered. 
Values obtained With the ratio normaliZing approach 
required When fractional cellular contents are extracted, can 
be substantially affected by the additional error contributed 
by variability in the “control” message to Which the target 
message is normaliZed, by different efficiencies (e.g., in 
PCR) betWeen the tWo messages, or by the very common 
occurrence in Which the normaliZing message is also up- or 
doWn-regulated in tandem, either by the conditions under 
investigation or by other conditions of the cell (e.g., siZe, 
metabolic activity) that affect both messages. The latter may 
sometimes provide a control for non-speci?c effects, but in 
more cases is likely to Wash out the absolute value of the 
target gene signal With Which the investigated function may 
be correlated. Further, it is becoming clear that differential 
targeting and distribution of mRNAs Within the cell (e.g., 
dendrites or soma) play critical roles in the CNS (SteWard et 
al., 1998; Kuhl and Shehel, 1998). The collection of mRNA 
by cytoplasmic extraction loses this differential distribution. 
Thus, Without the ability to obtain the full complement of 
mRNA With its topographic distribution intact, it Will clearly 
be dif?cult to estimate the total amount of a mRNA species 
in a neuron. In turn, this Will make it extremely dif?cult, in 
most cases, to draW quantitative conclusions about the 
relations betWeen gene expression and physiological func 
tion in individual cells. It should be noted that although the 
term “gene expression” is used here as a short hand some 
What interchangeably With mRNA content, this is only for 
purposes of simplicity and it is Well recogniZed that the tWo 
are not necessarily equivalent. In the present application, We 
focus only on the quantitation of total mRNA transcripts, but 
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controls are of course required in many types of experiment 
before concluding that mRNA content directly re?ects 
expression. 
Conventional Methods for mRNA Expression Measurement 
in the Brain 
The main available preparations are: a) HomogeniZed 
Tissues: Neuronal and glial heterogeneity generally prevents 
the accurate assessment of gene/mRNA expression relative 
to speci?c cell types or functions, even if small regions of 
brain are dissected, homogeniZed, and analyZed by conven 
tional methods (RPAs, Northerns) b) In Situ HybridiZation 
alloWs visualiZation of topographic mRNA expression in 
single cells, but because the tissue is ?xed, does not usually 
permit functional measures (electrophysiology, optical 
imaging) from the same cells or collection of the mRNA 
pool for subsequent ampli?cation; also, quantitative analysis 
(grain counting) is performed by sampling on one section, 
lending some error to the estimate of total mRNA; c) Acute 
Dissociation of brain neurons disrupts the membrane and 
amputates processes. It is not suitable for use With aged or 
even mature adult neurons as these are often highly trau 
matiZed by the procedure (Thibault et al., 1995a); in addition 
the loss of dendritic processes precludes studies of topo 
graphic differences in gene expression or collection of total 
mRNA; and d) Electrophysiological Whole Cell Recording 
(e.g., slices or culture) is compatible With many types of 
functional studies but generally collects mRNA by aspira 
tion of cytoplasmic content, Which as noted, is highly 
variable from cell to cell and prevents reliable collection of 
the full set of mRNA transcripts or separate study of somal 
and dendritic compartments. Further, the Whole-cell method 
dialyZes the cell’s interior Which can dilute substances that 
modify physiological function. 
Thus, despite the rapidly developing sophistication in 
measuring multiple gene expression, the currently available 
preparations are not Well suited for careful physiological 
expression correlation studies in the same neurons or even 
for collecting total mRNA in a single neuron. HoWever, as 
noted above, the partially-dissociated, or “Zipper”, brain 
slice (Gray et al., 1990), appears to have the potential to be 
a nearly ideal preparation for such studies in brain cells of 
mammals of any age range (Thibault et. al., 1995a; Thibault 
and Land?eld, 1996;Chen et al., 1998 and Preliminary 
Data). 
Function and Expression: Statistical Value of Single Cell 
Correlations 
It is becoming increasingly clear that there is considerable 
variability in the expression responses of different neuron 
types in the same brain region and even among different 
neurons of the same type. For example, it has been found 
that different neuron types and/or neurons of the same 
general phenotype can exhibit very different quantitative or 
topographical (dendrites vs. soma) patterns of distribution of 
the same mRNA species. One recent major study concluded 
that there are no general rules for mRNA localiZation that 
apply to all neuron types nor are there neuron-type-speci?c 
mechanisms that invariably regulate mRNA distribution 
(Paradies and SteWard, 1997). 
Thus, testing a hypothesis that some aspect of gene 
expression is directly linked to a speci?c function Will in 
many cases require correlational analyses of the degrees of 
association across these highly variable individual cellular 
patterns. Statistically, individual-sample correlation of 
course provides a more rigorous test than co-variance among 
group means, since the degrees of freedom (df) across Which 
a possible correlation can vary in a study of, say, 20 neurons 
in Which both a physiological process and mRNA content 
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are measured in response to a treatment in each neuron, 
Would be 19 [df=n-1(20-1)]. HoWever, if functional and 
expression values are obtained separately in different neuron 
groups (e.g., one set of neurons for recording, and one for 
mRNA), then the physiology-mRNA correlation can only 
vary around the number of experimental conditions (group 
means) and the associated degrees of freedom (e.g., treat 
ment or no treatment). Therefore, the many more df’s 
generally found in an individual sample correlation study 
alloW for clear statistical inferences and probabilistic state 
ments on the amount of variance in one variable that is 
accounted for by variance in the other. This is not possible 
for associations involving feW df’s (e.g., typically across 
group means) Which are consequently more susceptible to 
chance associations. 
A more general problem in this regard is that most major 
treatments or conditions (e.g., aging, seiZures, intense syn 
aptic stimulation, lesions, drugs, hormones, neurodegenera 
tive disease, developmental stages, etc.) presumably activate 
a large number of genes. As the neW microarray techniques 
for simultaneously assessing thousands of genes increas 
ingly come on line, it Will become extremely dif?cult to 
determine Which if the many observed changes in expression 
are relevant to function Without careful same-cell observa 
tions of both function and expression. Thus, the application 
of function-gene expression correlations in single cells (e. g., 
With large multiple regression correlation matrices and 
appropriate controls for performing many comparisons) may 
become one of the key ?rst steps in attempting to interpret 
Widespread gene activation in relation to function and in 
dealing With the vast quantities of data that the ?eld is on the 
threshold of obtaining. 
Prior Studies on Electrophysiology and Single Cell RT-PCR 
The vast majority of previous studies on electrophysi 
ological recording and RT-PCR in the same single neurons 
have, as noted, addressed all-or-none or message ratio 
questions, usually related to Whether or not a cell expresses 
a speci?c mRNA, and, if so, Whether or not it also manifests 
a particular physiological property. For example, the 
GABAA receptor is thought to be composed of 5 subunits, 
but there are almost 20 knoWn subunits and variants that can 
form the GABAA receptor. In transfected cells, different 
combinations can in?uence af?nity, pharmacological 
modulation, channel conductance and single channel kinet 
ics (e.g., Porter et al., 1992). HoWever the actual subunit 
combinations that occur in vivo are not knoWn. 
Consequently, many single cell recording-PCR studies have 
been used to determine Which subunits are expressed in 
Which cells, and hoW these combinations affect function 
(SudWeeks and TWyman, 1996). 
Although several prior studies have attempted semi 
quantitative analyses, a recent report (Tkatch et al., 1998) 
indicated a quantitative correlation betWeen an electrophysi 
ological function (K+ channel A-currents) and a measure of 
gene expression for a related subunit (mRNA for the Kv4.2 
K+ channel) in individual brain neurons. HoWever, that 
study Was performed in acutely dissociated basal ganglia 
neurons and therefore could not collect total mRNA. In 
addition, a feW studies in peripheral or invertebrate neurons 
have also quantitatively correlated physiological function 
and gene expression (e.g. Baro et al., 1997). But no one has 
accomplished the isolation of a single cell neuron having 
complexes processes as in an embodiment of the present 
invention. 
There is clearly an overall paucity of CNS single cell 
studies of electrophysiological function-gene expression 
correlations, very likely because of the limited availability 
of preparations compatible With quantitative analyses. 
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The Partially-Dissociated (“Zipper”) Slice. The partially 
dissociated slice preparation (often termed the “Zipper slice” 
for its tendency to gradually open, or unZip, along the cell 
body layers), Was originally developed by Gray, Johnston 
and colleagues (Gray et al., 1990) in young guinea pigs. The 
partial dissociation (unZipping) procedure involves mild 
enZymatic exposure to proteolytic enZymes and gentle 
“shaking” (FIG. 1). It provided unparalleled access to brain 
neurons for small patch pipettes and therefore yielded the 
high quality recordings needed for single channel analyses, 
With very little disturbance of cell structure. This adaptation 
incorporated someWhat shorter and loWer enZyme exposure 
and more gradual “unzipping” (Thibault et al., 1995a), and 
required several months to optimiZe. Of particular impor 
tance Was that the yield of high resistance (>20 GQ) 
recordings from healthy neurons Was equivalent from young 
adult, mid-aged and aged rat slices (Thibault and Land?eld, 
1996). Thus, With this preparation, We Were able to carry out 
the ?rst single channel analyses in brain neurons of aged 
mammals, and found an aging-related increase in the esti 
mated membrane density of available L-type voltage sensi 
tive Ca2+ channels (VSCC) (Thibault and Land?eld, 1996) 
(FIGS. 2, 3). 
Although each preparation has advantages for certain 
kinds of electrophysiological studies, it Was noted above that 
neither the acutely dissociated cell preparation nor the 
non-dissociated slice or culture preparation permits consis 
tent collection of the entire mRNA complement in a single 
cell. Aspiration of cytoplasmic contents through a Whole cell 
patch pipette, in either of these preparations yields a varying 
and unknoWn fraction of the mRNA content from cell to cell 
(e. g., signi?cant mRNA is likely trapped by organelles or the 
collapsing cell structure, and most dendritic mRNA is prob 
ably trapped in collapsing dendrites). 
Moreover, most current electrophysiological preparations 
are extremely limited in their usefulness for applications to 
mature adult, much less aged, animals. Cell cultures gener 
ally utiliZe embryonic or postnatal neurons and acute dis 
sociation techniques are usually focused on juvenile ani 
mals. In fact, We found that acute dissociation Was so 
traumatic for aged rat brain cells that almost none survived 
the dissociation procedure (Thibault et al., 1995a). Even 
most non-dissociated slice studies are performed on juvenile 
or very young adult animals (cf. revieWs, Thibault et al., 
1995a; 1998a). 
In the Zipper slice hoWever, the neuron that is being 
recorded With a cell-attached pipette can be easily and gently 
extracted from the slice, With nearly all of its processes 
intact simply by gradually WithdraWing the pipette While 
still maintaining negative pressure on the cell body. The 
entire long apical dendritic tree slides readily out of the slice 
still attached to the non-disrupted cell body. Most of the 
basilar dendrites also appear to be intact (FIG. 4). Aged 
animal neurons are extracted as readily and as non 
traumatically as are young. Thus, not only is the Zipper slice 
particularly suitable for large scale single channel recording 
studies, but it appears to be a neurobiological preparation 
that can provide a fully intact neuron With its morphological 
structure preserved, for analysis of gene expression. 
Although this preparation has usually been used With 
hippocampus, there appears to be no reason Why the prepa 
ration Would not Work from essentially any brain region, or 
With any tissue of an animal in an animal of any age. 
Another method that can yield semi-quantitative esti 
mates of mRNA expression in a single neuron that is largely 
topographically intact is in situ hybridiZation. HoWever, 
even this approach generally yields only a sample of total 
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mRNA (i.e., on the section through the cell) and can only be 
related to functional measures of the same cell With dif? 
culty. 
Limitations of the Zipper Slice 
Although the Zipper slice is presently extremely Well 
suited for ion channel and imaging studies (cf. beloW), its 
main limitation appears to be its sub-optimal suitability for 
synaptic studies. The Weakening of synaptic and tissue 
connections that makes it so ideally suited for cell extraction 
also results in variable synaptic connections, and therefore 
the Zipper slice yields inconsistent results in synaptic stud 
ies. HoWever, the present invention overcomes this limita 
tion and greatly expands the range of functional studies for 
Which the Zipper slice is highly valuable. 
SUMMARY OF THE INVENTION 
A method is described for isolating a single cell from its 
organ tissue, usually a neuron from neural tissue, While 
causing minimal disruption of the cell’s processes and 
membrane. The method of the invention comprises extract 
ing that cell from the tissue mass, Washing and transferring 
the cell, and then collecting the entire cell. In the case of 
neurons, the processes are substantially intact. 
The method of the invention further comprises determin 
ing the presence or amount of nucleic acid that is present in 
the extracted single cell. The inventive method comprises 
collecting the entire cell into a small pipette or tube ?lled 
With solutions and substances that facilitate the detection by 
ampli?cation or hybridiZation of the messenger ribonucleic 
acid (mRNA) transcripts. The cell membrane is then dis 
rupted and methods for ampli?cation and art-accepted mea 
surement techniques for measurement of small quantities of 
mRNA or deoxyribonucleic acid (DNA) are applied. 
In a preferred example, a brain slice from an experimental 
animal is placed in a perfusion chamber and kept alive by 
oxygenation and arti?cial cerebrospinal ?uid (ACF). The 
slice is then subjected to mild enZymatic concentrations and 
is nicked (cut) in a Way such that gradual dissociation of the 
slice occurs along the cell body layers. Gentle vibration 
enhances this dissociation. 
When the dissociation has proceeded suf?ciently to 
expose cell bodies, one of the cells is “patched” onto a glass 
patch pipette (electrode) using standard patch clamp record 
ing procedures. These procedures involve suction (negative 
pressure) in the pipette, and result in a tightly formed seal 
betWeen the cell membrane and the tip of the pipette. This 
tight seal facilitates loW noise ampli?cation and recording of 
the electrical activity of the cell. 
After the recording or other physiological monitoring 
session is completed, the cell is then pulled out of the tissue 
slice With most of its processes intact by maintaining the 
suction pressure of the pipette (electrode) and WithdraWing 
the pipette by use of its micromanipulator controls. The cells 
remain attached to the pipette tip and readily slide out of the 
tissue mass With this method. The nerve cell on the tip of the 
pipette is optionally Washed in clean ACF to remove extra 
neous mRNA and it is then transferred to a larger collection 
or harvesting pipette ?lled With an appropriate reverse 
transcriptase (RT) solution. The membrane is then disrupted 
osmotically to alloW the RT process to begin. The contents 
of the cell are then transferred again to a tube containing an 
appropriate solution for ampli?cation, for example, by poly 
merase chain reaction (PCR). Other methods for amplifying 
mRNA or DNA Would be equivalent to RT-PCR for pur 
poses of the invention. 
These and other objects of the invention Will be more fully 
understood from the folloWing description of the invention, 
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the referenced drawings attached hereto and the claims 
appended hereto. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows a schematic drawing of the hippocampal 
“Zipper slice” split along the major cell body layers. (From 
Gray et al., 1990). 
FIGS. 2A—2D shoW a Zipper slice preparation for record 
ing single Ca2+ channels from CA1 neurons from a young 
(A) and aged (B) hippocampal slices. (C) and (D) shoW ?ve 
depolariZations to +10 mV as Well as the average current 
ensembles beloW. Ensembles Were created from 15 such 
depolariZations. (From Thibault and Land?eld, 1996). 
FIG. 3 shoWs that L-type channel density Was obtained by 
estimating N from maximum simultaneous openings and 
calculating patch area from pipetted resistance. Channel 
density increased With aging (p<0.001) (n=19—35/group). 
(From Thibault and Land?eld, 1996). 
FIGS. 4A—4D shoW harvesting cells With intact neurites. 
A) The recording electrode is patched onto a CA1 pyramidal 
neuron and electrophysiologic data is recorded. B) The cell 
is then pulled from the slice using the recording electrode 
(note intact dendrites). C) The cell is cleaned of tissue debris 
by placing it at the inlet port of the perfusion chamber, Where 
uncontaminated bath solution ?oWs into the chamber. D) 
The apical dendrite is draWn into the collection pipette by 
capillary action. FolloWing this, position pressure applied to 
the recording pipette releases the cell in the collection 
pipette. (From Blalock et al., unpublished). 
FIG. 5 shoWs a summary of the steps involved in collec 
tion and molecular analysis of a recorded cell. 1) EnZymatic 
treatment (see methods) partially frees neurons from tissue, 
providing unobstructed access of the recording pipette to the 
cell membrane; 2) The cell is gently puled free of the tissue 
and collected. 3) The collected cell is transferred to a reverse 
transcriptase (RT) solution; 4) Subdivided into aliquots; 5) 
Each aliquot can then be ampli?ed for speci?c messages. 
FIG. 6 shoWs Ca2+ channel activity and (x1 D subunit 
mRNA expression are associated. Representative on-cell 
patch L-type Ca2+ channel activity (left) and (x1 D mRNA 
gels (right) shoW the 3 levels of electrophysiologic activity 
and mRNA expression (note a 202 bp (x1 D band at 45”1 and 
54m cycle #). Top. LoW levels of channel activity are 
associated With loW levels of expression. Middle. Medium 
levels of channel activity are associated With medium levels 
of expression. Bottom. High levels or activity are associated 
With high levels of expression. (From Chen et al., 1998). 
FIG. 7 shoWs that correlation betWeen channel activity 
and message level is speci?c for the message of interest. 
Top. Relationship betWeen Ca2+ channel activity and Ca2+ 
channel (x1 D mRNA level across individual neurons. A 
signi?cant positive correlation (rs=0.64, p<0.05, Spearman’s 
nonparametric test) Was found betWeen L-type Ca2+ current 
and (1.117 mRNA level (estimated by SC RT-PCR) across 
individual cells. On the vertical axis cells Were ranked 
according to mRNA level. On the horiZontal axis the same 
cells Were ranked according to channel activity. Bottom. 
Lack of correlation betWeen Ca2+channel activity and calm 
odulin (CaM) mRNA level. No signi?cant correlation (rS= 
0.07; n.s.; Spearman’s nonparametric test) Was found 
betWeen CaM mRNA level and L-type Ca2+ channel activity 
in the same cells as Top. (From Chen et al., 1998). 
FIG. 8 shoWs the localiZation of the (x1 D mRNA (in situ 
hybridiZation, ISH) and protein (immunoautoradiography, 
IAR) in adjacent hippocampal sections. Note the extensive 
overlap of signal for mRNA and protein in the tWo sections, 
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and the correspondence of the relative intensities of ISH and 
IAR in dentate gyrus (DG) vs CA1 and CA3. 
FIGS. 9A—9B shoW confocal microscopic analysis of (x1 D 
immunoreactivity in 0.5 pm optical sections from hippoc 
ampal slice preparations. Panel A illustrates an example of 
a confocal image of tWo distinct cells in CA3 (arroWs). 
Images shoW punctate immunoreactivity localiZed in the cell 
cytoplasm and membrane regions. Frequency distribution 
(B) of single-cell ?uorescence intensity from 0.5 pm optical 
sections. All measures Were taken from cells Wholly con 
tained Within the thickness of the tissue section, and Were 
sampled from the optical section containing the greatest 
staining area from the cell. 
FIG. 10 shoWs capturing cells from the Zipper prepara 
tion. A) Cell soma and neurites are Well exposed by enZy 
matic treatment and Ca2+ channel activity is recorded. B) 
Post-recording the cell is gently pulled aWay from the slice 
and C) collected With a harvest pipette. 
FIG. 11 shoWs Indo1 loaded CA1 neuron in an intact slice. 
Image reconstructed from multiple transients. 30 FIG. 12 
shoWs examples of Indo1-AM-loaded CA1 neurons in the 
“Zipper” slice preparation. 
FIG. 13 shoWs transection of the major dendritic process 
of a hippocampal neuron in culture during simultaneous 
Whole-cell patch clamp recording of Ca2+ currents (Na+ and 
K+ currents blocked by TTX, TEA and Cs). 
With the neuron’s membranes potential voltage clamped 
at —70 mV, transection of the large process did not cause 
disruption of the recording con?guration, or alter the Whole 
cell Ca2+ currents. Similar results have been obtained in 
many other neurons. (From Thibault et al., 1995b). 
DETAILED DESCRIPTION OF THE 
INVENTION 
Many studies have examined RT-PCR or other methods of 
ampli?cation of mRNA or DNA contents of a single brain 
cell after recording procedures (see revieW in Monyer and 
LamboleZ, 1995; SudWeeks and TWyman, 1996; and Mack 
ler and EberWine, 1993). HoWever, all of these prior studies 
have either extracted the internal contents of the cell by 
aspiration, after breaking the membrane, or used acute 
dissociation procedures to isolate the cells. Unlike the partial 
dissociation method used in this application, the acute 
dissociation procedures massively disrupt the cell’s plasma 
membrane and amputate most of its processes (Kay and 
Wong, 1982). 
A signi?cant aspect of the invention is the adaptation or 
partially dissociated tissue (e.g., slices) for the neW use of 
gene/mRNA expression analyses as Well as a method for cell 
transfer and preparation that Works to provide accurate 
estimates of the relative numbers of an mRNA transcript 
type Within a single physiologically characteriZed brain cell. 
The invention is directed to a method for extracting a 
single cell from a complex intertWined biological tissue 
Without massively disrupting its structure and/or its plasma 
membrane. The major advantage of this method for any 
molecular or biochemical analysis of molecular contents of 
the cell is that the entire set of the cell’s mRNA transcripts 
or other molecular species is captured. Conventional meth 
ods inevitably lose some of the contents during aspiration or 
acute dissociation, because of leakage after membrane 
disruption, collapse of the cell’s structure and trapping of 
contents, loss of large processes and other causes. This loss 
of molecular contents is variable and unknoWn from cell to 
cell and therefore all measures of contents obtained by these 
conventional procedures must be normaliZed as ratios to 
US 6,420,105 B1 
other substances of the cell. The other substances are usually 
very heterogenous (e.g., total RNA) or are potentially sub 
ject to different and variable forms of regulation than the 
substance of interest (e.g., another mRNA species). This 
technical problem adds great additional sources of variation 
to single cell measures of mRNA collected by conventional 
means, and therefore has been one major impediment to 
detailed quantitative analyses in single neurons. 
The method of the invention has the important advantage 
over conventional methods in that it alloWs the collection 
and ampli?cation of the full cell contents of a molecular 
species and therefore, provides the potential for more accu 
rate measurement of single cell molecular content. 
Moreover, many tissues are heterogeneous and contain 
diverse cell types, Which is particularly true for the Central 
Nervous System (CNS), and therefore, measurement from 
tissue homogenates can be confounded. The ability to mea 
sure accurately the molecular contents of a single cell Will 
circumvent this problem of this confounding heterogeneity. 
Further, a second recogniZed advantage of being able to 
measure single cell contents is that it confers the ability to 
correlate gene expression of a cell, for example, With the 
physiological function or other phenotype of the same cell, 
thereby greatly facilitating the analysis of functional conse 
quences of gene expression. With the rapid advent of neW 
technologies for measuring expression of thousands of genes 
at a time (e.g., DNA chip technology) the ability to deter 
mine Which are most closely correlated With function and 
phenotype Will be increasingly important. 
Athird major advantage of the method of the invention is 
that it captures the cell With its molecular contents still 
distributed anatomically Within the cell in a topographical 
pattern similar to that found in vivo. This is because the cell 
structure has not collapsed and the processes are intact. In 
neurons, for example, it is increasingly recogniZed that 
protein synthesis can occur in dendrites and that the mRNAs 
found in dendrites are different quantitatively from those 
found in the soma (SteWard et al, 1998). Therefore, obtain 
ing the entire neuron With dendritic processes intact Will 
greatly facilitate the detailed analysis of molecular regula 
tion in different regions of the cell, Which Will enhance the 
understanding of the function of dendritic mRNA. 
Although the method has been developed in the brain, and 
seems particularly Well suited for CNS studies, it is to be 
understood that the invention is not limited to isolation of 
neurons. The inventive method can be applied to the isola 
tion of a single cell from any tissue source, such as, kidney, 
endocrine glands, and so on. Any use of a gentle partial 
dissociation procedure and capture of a complex single cell 
With its processes substantially intact and Without membrane 
disruption, or disruption of the processes, With the goal of 
more accurately quantifying the content and/or distribution 
of a molecular species in a cell are encompassed by the 
invention. 
The invention has been developed initially and validated 
for mRNA of speci?c genes, but the application of these 
procedures for accurate measurement of any molecular 
species, including proteins, lipids or other biochemical sub 
stances are encompassed by the invention. 
The invention also encompasses any variation in Which a 
neuron or other complex cell type Was collected and then 
speci?c parts of that cell Were dissected, amputated or 
isolated, for purposes of selectively measuring molecular 
contents in the dissected component or fraction. 
The present invention is also directed to a novel use of 
partially dissociated tissues for collecting and measuring an 
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entire neuron largely intact and With its full set of molecular 
contents. The present application also describes neW meth 
ods for achieving this by extracting and collecting an 
individual cell Without substantially disrupting its mem 
brane. The present application provides evidence and 
describes procedures shoWing that this use is feasible and 
reliable. In particular, the present invention also describes 
methods for dissecting dendritic parts of an extracted neu 
ron. These methods for extracting, Washing and transferring 
a cell have been validated in our laboratory by shoWing that 
RT-PCR of the mRNA contents for a Ca2+ channel gene is 
highly consistent across different cells and also correlates 
semi-quantitatively With phenotypic expression of the 
appropriate Ca2+ channel. Thus, the present inventors are the 
?rst to propose and illustrate the collection of the entire 
contents of a largely undisrupted cell from a complex tissue 
such as the CNS. 
One aspect of the invention is to de?ne optimal conditions 
of enZymatic exposure (concentration, duration, 
oxygenation, temperature, etc.) that alloW single neuron 
extraction from multiple brain areas With the least distur 
bance of mRNA content. Single cell PCR and in situ 
hybridiZation Will be run in parallel to cross-validate the 
conclusions. Three to ?ve Ca2+-regulatory genes (mRNA) 
Will be examined in adult and aged rats and subsequently, 
mice. 
Another aspect of the invention is to develop optimal 
methods for examining mRNA and protein content in the 
same Zipper slice neurons, by taking alternate sections for in 
situ hybridiZation and immunoautoradiography. In other 
studies, a single neuron Will be extracted from a Zipper slice 
gently placed on a coated glass slide and ?xed and strained 
With antibodies. TWo methods for studying mRNA in the 
same cell Will also be compared: in situ hybridiZation or 
RT-PCR, in both rats and mice. 
Another aspect of the invention is to extend the range of 
functional studies for Which the Zipper slice can be utiliZed 
by developing neW techniques to “unzip” the slice after the 
functional studies are performed rather than before, as is 
presently done. The major advantage Will be that functional 
studies can then be performed before synaptic contacts are 
altered by even the mild enZymatic exposure of the current 
method. TWo methods Will be compared for ?nding and 
extracting the same recorded cell after the partial dissocia 
tion procedures: 1) loading With Ca2+-sensitive dye during 
recording (before partial dissociation), and ?nding that same 
cell on the CLSM after partial dissociation; and 2) main 
taining pipette contact With the cell after recording is 
completed, during subsequent gentle dissociation in the 
recording chamber. Once this technique is established in 
rats, are extended directly to mouse slices. 
Another aspect of the invention is to develop methods to 
separate dendritic and somatic morphological compartments 
for independent PCR analyses. Several methods of dissect 
ing the apical dendrite aWay from the soma and cutting it 
into separate pieces are compared. 
Still another aspect of the invention is to extend the single 
cell RT-PCR approaches of the invention to neW technolo 
gies for large scale expression pro?les by adapting and 
validating methods for amplifying the mRNA pool of a 
single cell. We develop proportional ampli?cation of mRNA 
transcripts to a degree that Will be compatible With large 
scale expression pro?ling using both neW “DNA chip” 
microarray technology and a 96-well PCR format. Technol 
ogy such as real-time PCR, TaqMan®, ABI PRISM 7700 
Sequence Detection System, and laser-activated DNA 












